Semaglutide SM40 40mg*10vials

Smegglutide SM40 (40mg x 10 vials) is a high-purity, research-grade GLP-1 receptor agonist, belonging to a high-end peptide series for weight and metabolism research. This product features optimized molecular stability and high receptor binding activity. The 40mg high-concentration formulation is professionally purified and suitable for advanced preclinical metabolic studies. Compared to traditional low-dose smegglutide, this product offers superior solubility, more stable batch-to-batch consistency, and higher experimental purity. Manufactured using rigorous multi-stage purification and vacuum lyophilization technology, the lyophilized powder structure effectively locks in biological activity, preventing molecular degradation and efficacy attenuation during storage and experimentation, fully meeting the high standards of professional laboratories and drug research institutions.

Product Function and Research Value

As a core long-acting GLP-1 analogue research reagent, smegglutide SM40 selectively activates GLP-1 receptors, exerting a stable and effective regulatory effect on the body's metabolic axis. In laboratory studies, SM40 is widely used to explore core mechanisms including appetite signal regulation, calorie intake control, glycemic homeostasis, improved insulin sensitivity, and systemic adipose metabolic remodeling. Unlike conventional semaglutide formulations, which are less potent and have unstable efficacy, the 40mg high-dose SM40 formulation offers stronger and longer-lasting bioactivation, supporting in-depth research into weight management mechanisms, glycemic regulation, metabolic disorder intervention, and energy balance regulation. Its highly controllable dose-response relationship effectively reduces experimental error, providing reproducible and accurate research data, suitable for long-term metabolic intervention modeling, high-dose gradient efficacy testing, and studies of the synergistic effects of complex peptides.

Core Product Advantages

1. Highly Active GLP-1 Receptor Activation: Optimized molecular structure endows it with excellent receptor affinity, stably activating downstream metabolic signaling pathways, supporting in-depth research into glucose and lipid metabolism and appetite regulation mechanisms.

2. 40mg Ultra-High Concentration: A high-quality, high-dose formulation meets the needs of various high-intensity experiments, overcoming the limitations of insufficient efficacy and short duration of action of low-dose products, making it an ideal choice for advanced preclinical studies.

3. Excellent Solubility and Stability: The lyophilized powder can be rapidly and completely reconstituted with antibacterial water, resulting in a uniform solution concentration, long-term biostability, and freedom from ineffective impurities.

4. Strict Purity and Batch Consistency: Utilizing pharmaceutical-grade purification processes and HPLC testing, the product boasts high purity. Standardized batch production ensures consistent experimental results and reliable research data.

5. Professional Laboratory Packaging: Each box contains 10 vials, aseptically packaged, and comes with a complete Certificate of Authorization (COA). Suitable for academic laboratory research, preclinical drug development, and global bulk wholesale procurement.

Smiglitide SM40 40mg*10 vials is a high-purity, long-acting GLP-1 receptor agonist research peptide suitable for studies on advanced metabolism and weight management mechanisms. This product features high concentration, excellent solubility, and stable bioactivity, supporting laboratory studies in appetite regulation, glycemic control, and lipid metabolism remodeling. HPLC testing and a complete COA are provided, making it available for global wholesale.